Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Human Immunology
|
February 1, 1991
A rare HLA DQB allele sequenced from patients with systemic lupus erythematosus
Z Fronek, L A Timmerman, H O McDevitt
Clinical Immunology and Immunopathology
|
October 1, 1986
The relationship between Sm and RNP antigens
Z Fronek, R R Valle, R B Eaton, et al.
The Journal of Investigative Dermatology
|
November 1, 1991
Molecular analysis of HLA DP and DQ genes associated with dermatitis herpetiformis
Z Fronek, M M Cheung, A M Hanbury, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 1990
Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus
C O Jacob, Z Fronek, G D Lewis, et al.
Arthritis and Rheumatism
|
August 1, 1986
Systemic lupus erythematosus is not genetically linked to the beta chain of the T cell receptor
Z Fronek, D Lentz, N Berliner, et al.
Arthritis and Rheumatism
|
October 1, 1990
Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus
Z Fronek, L A Timmerman, C A Alper, et al.
The American Journal of Medicine
|
December 23, 1988
Major histocompatibility complex associations with systemic lupus erythematosus
Z Fronek, L A Timmerman, C A Alper, et al.
Arthritis and Rheumatism
|
July 1, 1990
Idiotypic characteristics of immunoglobulins associated with human systemic lupus erythematosus. Association of high serum levels of IdGN2 with nephritis but not with HLA class II genes predisposing to nephritis
B H Hahn, K C Kalunian, Z Fronek, et al.
Science (New York, N.Y.)
|
May 20, 1988
A molecular basis for MHC class II--associated autoimmunity
J A Todd, H Acha-Orbea, J I Bell, et al.
The Journal of Rheumatology
|
August 1, 1996
V beta 17 T cell receptor peptide vaccination in rheumatoid arthritis: results of phase I dose escalation study
L W Moreland, L W Heck, W J Koopman, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Human Immunology
|
February 1, 1991
A rare HLA DQB allele sequenced from patients with systemic lupus erythematosus
Z Fronek, L A Timmerman, H O McDevitt
Clinical Immunology and Immunopathology
|
October 1, 1986
The relationship between Sm and RNP antigens
Z Fronek, R R Valle, R B Eaton, et al.
The Journal of Investigative Dermatology
|
November 1, 1991
Molecular analysis of HLA DP and DQ genes associated with dermatitis herpetiformis
Z Fronek, M M Cheung, A M Hanbury, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 1, 1990
Heritable major histocompatibility complex class II-associated differences in production of tumor necrosis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus
C O Jacob, Z Fronek, G D Lewis, et al.
Arthritis and Rheumatism
|
August 1, 1986
Systemic lupus erythematosus is not genetically linked to the beta chain of the T cell receptor
Z Fronek, D Lentz, N Berliner, et al.
Arthritis and Rheumatism
|
October 1, 1990
Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus
Z Fronek, L A Timmerman, C A Alper, et al.
The American Journal of Medicine
|
December 23, 1988
Major histocompatibility complex associations with systemic lupus erythematosus
Z Fronek, L A Timmerman, C A Alper, et al.
Arthritis and Rheumatism
|
July 1, 1990
Idiotypic characteristics of immunoglobulins associated with human systemic lupus erythematosus. Association of high serum levels of IdGN2 with nephritis but not with HLA class II genes predisposing to nephritis
B H Hahn, K C Kalunian, Z Fronek, et al.
Science (New York, N.Y.)
|
May 20, 1988
A molecular basis for MHC class II--associated autoimmunity
J A Todd, H Acha-Orbea, J I Bell, et al.
The Journal of Rheumatology
|
August 1, 1996
V beta 17 T cell receptor peptide vaccination in rheumatoid arthritis: results of phase I dose escalation study
L W Moreland, L W Heck, W J Koopman, et al.
Page
of 2